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Combinatorial approaches to catalysis have made an impact in targeted transformation
development, including Ag-mediated carbene insertion,[1] Sc-pybox-based asymmetric
cyclopropanation,[2] and Rh/Ir-based asymmetric hydrogenation.[3] Useful design elements
have emerged from these studies, e.g. the value of ligand self assembly,[4] or of the inclusion
of peptide-like structural elements[5],[6],[7] in building ligand arrays. Efficient screening
methods are of paramount importance for such efforts. Methods based on fluorescence,[8]
REMPI,[9] MS,[10] NMR,[11] and IR thermography[12] have appeared. A chromophore may
be installed into the substrate[13] or product[14] of the reaction under study. Alternatively,
one can exploit chromophores inherent in proteins[15] or enzyme-associated reactions,[16]
and use these sensors to report back on product formation and composition.
Our group has developed an in situ enzymatic screening (ISES) approach whereby an
organometallic reaction under study is coupled to an enzymatic reporting reaction in real
time.[17] This screening method led to the discovery of the first asymmetric allylic amination
with Ni(0)[18] and to the identification of novel salen ligands with promise for asymmetric
synthesis.[19] Those approaches involved dehydrogenase enzymes[20] as sensors, utilizing
the inherent nicotinamide cofactor to provide a UV signal.
This Communication describes an important new ISES-mode in which the reporting
enzymes lead to a visible signal in real time. The advantages of colorimetric approaches
have been articulated[13, 21] and include the ability to screen a diverse array of catalysts with
the naked eye, without employing specialized equipment, increasing convenience and
throughput.
Synthetically, this study was directed at developing formal halometalation/carbocyclization
transformations. One can envision this providing a rapid entry into the cores of terpenoid
natural products featuring exomethylene γ-lactones (Scheme 1). The 6-exo-trig substrate 6
would lead into cores of xerophilusin and crassin, a specific modulator of STAT
phosphorylation.[27] The 5-exo-trig substrate 3 is designed to give 5,7-sesquiterpenoid
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lactone cores.[28] Key natural products (NPs) here include the guaianolide, ixerin Y (1),[29]]
and xanthatin (2), which shows anti-MRSA,[30] antifungal[31] and anti-ulcer[32] activity.
Related NP-derived α-methylene butyrolactone moieties appear to Michael-add Cys-38[33]
of the transcription factor NF-κB,[34] thereby blocking DNA binding.[35] Our synthetic
approach is particularly attractive in light of such SAR postulates, as it would deliver the NP
core with a β-halo-α,β-unsaturated lactone moiety, for potential target capture, in vivo, and
also to tap into cross-coupling chemistry ex vivo, for chain extension/library elaboration.
The drive toward streamlined methods for the construction of such NP cores is motivated by
the effectiveness of NP-core based chemical biology libraries in defining studies by groups
such as Schreiber,[22] Waldmann,[23] Shair, [24]Arndt [25]and Snapper.[26]
While the chemistry envisioned in Scheme 1 remained largely unexplored, there was some
precedent from the work of Lu,[36] primarily with acetoxy-metalation/carbocyclization,
employing Pd(II) catalysis in neat acetic acid[37] as solvent. We set out to examine a much
broader spectrum of metal, (pseudo)halide and substrate space, combinatorially, using visual
colorimetric-ISES for higher throughput.
We demonstrate herein that the combination of alcohol oxidase and peroxidase serves as an
effective reporting duo for the title transformation (Figure 1). By utilizing ABTS [2,2-azino-
bis(3-ethylbenzothiazoline-6-sulfonate)], as peroxidase cofactor, one achieves particular
sensitivity. This is because each molecule of alcohol (by)product emanating from the
organic reaction of interest that is oxidized by the alcohol oxidase reporter gives rise to two
equivalents of ABTS radical cation, providing for an intense (ε405-414 (2 ABTS.+) ~ 70,000
M−1cm−1) [38] colorimetric signal in the visible range (jungle green). This allows for first
pass scanning of a large number of potential catalytic combinations with the naked eye
(Figure 2). A more quantitative ranking (relative rates) may then be obtained by UV-visible
spectrophotometry on first pass hits (Fig. 3).
A broad array of 64 metal catalyst candidates was chosen; subdivided into 4 groups of 16
catalysts each, as detailed in the SI. These were screened against 6 (pseudo)halides (LiF,
LiCl, LiBr, LiCN, LiOCN, LiSCN) and 3 candidate substrates (3, 7, 8), creating a 64x6x3
=1152 combinatorial array. Figure 2 shows a 96 well tray for the metal set III vs. substrate 3.
These were run in a convenient 300 μL format (200 μL organic/100 μL aq. enz). One sees
clear positive readouts for the combination of LiBr with both Rh(II)-perfluorocarboxylates
(in contrast to the Rh(II) carboxylate catalyst), as well as with Pd(II)(acac) [but not Ni(II)
(acac)] and Cl2Pd(NCPh)2 [but not Cl2Pt(NCPh)2].
The most interesting hits in the colorimetric tray screen were next “cherry-picked” visually,
and then ranked more quantitatively by spectrophotometric analysis in the cuvette (Fig. 3).
As can be seen, for Pd(II), the cyclization chemistry proceeds efficiently with (PhCN)2PdCl2
and LiBr for both the 5-exo-trig-ester and –ether substrates. Acetic acid clearly is not
necessary for these cyclizations. Among other Pd(II) catalysts screened, Pd(acac)2, gave the
next fastest rates.
However, the most generally effective catalytic combination found was LiBr with the
Rh(II)-perfluorocarboxylates, providing efficient formal bromorhodiation/carbocyclization,
across all three test substrates, in stark contrast to Rh(II)-acetate dimer, and all Rh(I)- and
Rh(III)-complexes examined. This reactivity was verified under standard RB flask
conditions, through which product identity, stereochemistry and yield were established
(Figure 4). Note that the cyclizations are highly diastereoselective, giving the 1,2-trans
stereochemistry for the xanthatin core from 3, and the 1,3-cis stereochemistry for the
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crassin-type core from 7. Also of interest, catalyst loading could be lowered to 2.5 mol%,
without compromise in yield, by gentle heating or sonication (SI).
This would appear to constitute a new reaction mode for the Rh(II)/LiX combination.
Control experiments established that this reactivity is not a function of stray TFA (see SI).
The disparate reactivity of Rh(II)-perfluorocarboxylates vs. Rh(II)-carboxylates is
reminiscent of observations by Padwa and Doyle, the tendency of only the former to
promote electrophilic aromatic substitution over carbene insertion.[39] Clearly this unusual
and valuable reactivity warrants further exploration.
Perhaps of equal significance, the combination of (PhCN)2PdCl2 with LiSCN yields an
unprecedented formal thiocyano-palladation/carbocyclization transformation. As such, this
reaction manifold assembles a cyclic NP-core bearing a terminal vinyl thiocyanate in one
operation [Note: product structure verified both spectroscopically and chemically-SI]. Given
the importance of the thiocyanate functionality for elegant vibrational Stark effect studies or
active site environmnet by Boxer,[40] this transformation will likely be of real value to
chemical biologists.
We next utilized the new Rh(II)-perfluorocarboxylate chemistry to fashion a small
xanthatin-core library, based upon stereo-controlled synthesis, followed by tailoring
chemistry (Scheme 2). Alpine-Borane-mediated ynone reduction establishes the absolute
stereochemistry,[41] (see SI), while the bromometallation/carbocyclization sets the relative
stereochemistry. Finally, RCM yields the desired xanthanolide core, with the
bromomethylene lactone undergoing Pd-mediated chain extension reactions as projected
(Scheme 3).
Note that the standard Sonagashira coupling proceeds with double bond migration, yielding
bicyclic dienoate in 15. Use of modified Stille conditions (i.e. stannylated acetylene)
prevents this to give ynenoate 16. All analogues feature more extended Michael acceptors of
potential interest, given the mechanistic hypothesis that has been advanced (vide supra). In
summary, the first application of visible, colorimetric ISES has uncovered both a
generalizable Rh(II)-mediated halometalation/carbocyclization and the first formal
thiocyanometalation/carbocyclization. Current efforts are to explore the scope of these new
tandem bond constructions, and of the colorimetric screen that led to their discovery.
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a) - Configuration of this in situ screen; b) – UV spectrum for the formation of ABTS radical
cation with time; c) – potential catalytic combinations screened
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Example of a d9-d10 screening array for substrate 3 –sixteen metal complexes are screened
across six (pseudo)halides with propiolate ester 3 (5-exo-trig substrate).
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Initial hits from visual colorimetric-ISES are ranked spectrophotometrically (Abs405 in
mAbs min−1; A, B and C are respectively substrates 3, 7 and 8-see SI for conditions). Right
side: example of the cuvette-ISES experiment. Note: The ABTS indicator shows turnover
with Rh(II)-perfluorobutyrate, while the highly colored Rh(III) catalyst fails.
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Chart showing success of catalytic metal-(pseudo)halide combinations as a function of
substrate. Isolated yields for homogeneous material, following standard RB flask reactions
(*reaction carried out at 60°C; **GC yield)
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Proposed halometalation/carbocyclization routes into the core structures of terpenoid
exomethylene lactone natural products.
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Application of the new halometalation/carbocyclization route to the stereocontrolled
synthesis of the xanthatin core.
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Exploitation of the bromomethylene lactone functionality for transition metal-mediated
tailoring chemistry upon the bicyclic xanthanolide core: (a) HCC-TMS, Cui, Cl2Pd (PPh3)2,
Et2NH; (b) Bu3SnCC-TMS, cat. Pd2dba3, Pfur3, Δ (c) BrZnC(Ph)C=CH2, Pd(PPh3)4 Δ. (d)
Bu3SnCH=CH2, Pd2dba3, Pfur3, Δ.
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